このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Automatic Prosthetic Foot Stiffness Modulation to Improve Balance in the Real World

Automatic Activity-Dependent and Phase-Varying Prosthetic Foot Stiffness Modulation to Improve Balance Control in Individuals With Lower-Limb Amputations in the Real World

The goal of this clinical trial is to determine if automatic stiffness modulation improves balance control in ambulatory individuals with below-knee amputations in real-world conditions. The main question this clinical trial will answer is:

• Can a user-specific automatic stiffness prosthesis improve balance control compared to user's fixed stiffness prosthesis that was clinically prescribed?

Participants will perform free-ranging ambulatory activities outside the laboratory that include nine ambulatory activities of daily living (walking at different speeds, turning, ramp ascent/descent, while carrying a load, and while walking on uneven terrain) while wearing, in random order, 1) a fixed stiffness prosthesis that was clinically prescribed and 2) an automatic stiffness prosthesis that uses an open source ankle configured to implement a user- and activity-specific automatic stiffness modulation control scheme intended to improve balance control.

調査の概要

詳細な説明

Individuals with lower limb amputations are at higher risk of falling compared to able-bodied and other clinical populations and are more likely to sustain life-altering injuries. The higher fall risk is primarily due to the loss of muscles crossing the ankle, which are critical to maintaining balance control. Prosthetic devices are designed to provide appropriate stiffness for needed stability and support. While research has shown the optimal stiffness to maintain balance varies across ambulatory activities (e.g., straight walking versus turning), most clinically prescribed prosthetic devices are passive and only provide a fixed stiffness level. The one commercially available, powered prosthetic ankle-foot, has not been shown to restore balance control. Thus, a prosthetic device that actively adjusts ankle stiffness across different ambulatory activities is critically needed to advance the field and improve balance control for those with lower-limb amputations. The goal of this clinical trial is to identify prosthesis stiffness that optimizes balance control in individuals with below knee amputations as they perform typical ambulatory activities of daily living. By matching the ankle stiffness to the task requirements, the investigators believe balance control will significantly improve and fall risk will decrease for those with lower-limb amputations.

Each participant will be fit with a novel prosthesis that includes a low-profile prosthetic foot whose stiffness category will be determined by their body weight and activity level (standard clinical practice), a prosthetic foot whose stiffness category is two categories stiffer, and another whose stiffness is two categories less stiff. Participants will continue to use their existing prosthetic socket and suspension system, but their pylon length will be adjusted as needed. While wearing the different study prostheses in randomized order, nine ambulatory activities will be performed in a motion capture laboratory.

  1. Walking on level ground at self-selected speed.
  2. Walking on level ground at 15% slower than self-selected speed.
  3. Walking on level ground at 15% faster than self-selected speed.
  4. Walking up an 8% slope at self-selected speed.
  5. Walking down an 8% slope at self-selected speed.
  6. Walking on level ground at self-selected speed while carrying a 5 kg load in one hand on their prosthetic side.
  7. Walking on level but uneven terrain at self-selected speed.
  8. Walking around 2-meter diameter circle at self-selected speed with the prosthetic side on the inside of the circle.
  9. Walking around 2-meter diameter circle at self-selected speed with the prosthetic side on the outside of the circle.

Ambulatory activities 1 through 6 will be performed on an instrumented treadmill. The load to be carried in activity 6 will be configured as a grocery bag with handles. Activity 7 will be performed on a rocky terrain treadmill. Activities 8 and 9 will be performed overground across five force plates embedded in the laboratory floor while following the outline of a 2-meter diameter circle. Rest breaks during all activities will be provided as needed.

The data from this experiment will be used to calculate the peak-to-peak range of the frontal plane whole-body angular momentum (a measure of balance control). The investigators will use these calculations to determine a user- and activity-specific automatic stiffness modulation control scheme intended to improve balance control.

Each participant will then be randomized to wear their fixed stiffness prosthesis or the automatic stiffness prosthesis. Subjects will be fit with the IMU sensors on their ankles, wrists, and upper torso. The automatic stiffness prosthesis will be programmed to emulate the user-specific and activity-specific automatic stiffness modulation control scheme. Subjects will be provided at least 10 minutes to walk about the laboratory to learn how the study prosthesis performs. Subjects, wearing the study prosthesis (fixed or automatic stiffness), will then walk a defined course about the hospital facility (both indoors and outdoors) in which each of the laboratory-based ambulatory activities will be represented. A study investigator will accompany the subject at a following distance of ~5 meters while video recording their gait. After completing the defined course, the subject will return to the laboratory where they will complete the Prosthetic Limb Users Survey of Mobility and the Activities-Specific Balance Confidence Scale questionnaires to assess their perceived functional mobility and balance confidence. The subject will then don the other study prosthesis (fixed or automatic stiffness) and then repeat the walk about the defined course and complete the two questionnaires a second time.

The results of this experiment will determine if automatic stiffness modulation improves the balance control of those with lower-limb amputation as they perform typical ambulatory activities of daily living using both biomechanical analyses and self-report assessments of perceived functional mobility and balance confidence.

The investigators hypothesize that the automatic stiffness prosthesis will provide improved balance control in real-world environments compared to the user's fixed stiffness prosthesis that was clinically prescribed. The investigators further hypothesize that the Prosthetic Limb Users Survey of Mobility score reported after wearing the automatic stiffness prosthesis will be greater than the score reported after wearing the fixed stiffness prosthesis, and the Activities-Specific Balance Confidence Scale score reported after wearing the automatic stiffness prosthesis will be greater than the score reported after wearing the fixed stiffness prosthesis.

研究の種類

介入

入学 (推定)

20

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Washington
      • Seattle、Washington、アメリカ、98108
        • VA Puget Sound Healthcare System
        • 主任研究者:
          • Glenn K Klute, PhD
        • コンタクト:
        • コンタクト:
        • 主任研究者:
          • Richard R Neptune, PhD

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Unilateral transtibial (below-knee) amputation
  • Been fit with a prosthesis and used it for at least 6 months
  • Wear the prosthesis for 4 or more hours on average per day
  • Be at least one-year post-amputation
  • Able to walk on a treadmill

Exclusion Criteria:

  • Presence of disorder, pain, or injury other than amputation that interferes with gait
  • Current skin irritation or injury on residual limb
  • Use of an assistive device for walking (cane, walker, etc.)

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:Fixed stiffness prosthesis then automatic stiffness prosthesis

A within-subject crossover experiment will be conducted to determine if differences in balance control (peak-to-peak range of frontal plane whole body angular momentum) exist between two study prostheses. The two study prostheses include (1) the participant's fixed stiffness prosthesis and (2) a novel, automatic stiffness prosthesis. The order in which participants wore the study prostheses was randomized.

The study will be conducted over 2 weeks. All participants will walk a defined course (both indoors and outdoors) about a hospital facility.

Participants in this group will wear their fixed stiffness prosthesis first and then the automatic stiffness prosthesis.

The participant's clinically prescribed prosthesis whose stiffness category is determined by the person's body weight and activity level (standard clinical practice).
A novel prosthesis whose user-specific and activity-specific stiffness profile is automatically modulated based on their ambulatory activity.
実験的:Automatic stiffness prosthesis then fixed stiffness prosthesis

A within-subject crossover experiment will be conducted to determine if differences in balance control (peak-to-peak range of frontal plane whole body angular momentum) exist between two study prostheses. The two study prostheses include (1) the participant's fixed stiffness prosthesis and (2) a novel, automatic stiffness prosthesis. The order in which participants wore the study prostheses was randomized.

The study will be conducted over 2 weeks. All participants will walk a defined course (both indoors and outdoors) about a hospital facility.

Participants in this group will wear the automatic stiffness prosthesis and then their fixed stiffness prosthesis.

The participant's clinically prescribed prosthesis whose stiffness category is determined by the person's body weight and activity level (standard clinical practice).
A novel prosthesis whose user-specific and activity-specific stiffness profile is automatically modulated based on their ambulatory activity.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
前額面全身角運動量のピークツーピーク範囲
時間枠:研修訪問中(約3時間)
前額面の全身角運動量は、外力やトルクがない場合に人が前額面で回転する程度の尺度です。 ピークツーピークの範囲は、この指標がどの程度変化するかを定量化し、人のバランスを説明するために使用されます。
研修訪問中(約3時間)

二次結果の測定

結果測定
メジャーの説明
時間枠
Prosthetic Limb Users Survey of Mobility
時間枠:During study visit (approximately 3 hours)
The Prosthetic Limb Users Survey of Mobility is a self-report instrument designed to measure the mobility of adults with lower limb amputations, utilizing a set of calibrated questions to assess perceived mobility in various activities. The Prosthetic Limb Users Survey of Mobility has been recommended by the National Institute of Child Health and Human Development as a core Common Data Element for lower-limb loss research as outcome measures to assess mobility.
During study visit (approximately 3 hours)
Activities-Specific Balance Confidence Scale
時間枠:During study visit (approximately 3 hours)
The Activities-Specific Balance Confidence Scale is a 16-item self-report questionnaire that measures an individual's confidence in performing daily activities without losing balance or feeling unsteady. It is widely used to identify individuals at risk of falls and to guide interventions aimed at improving balance and mobility. The Activities-Specific Balance Confidence Scale has been recommended by National Institute of Child Health and Human Development as a core Common Data Element for lower-limb loss research as an outcome measure to assess balance.
During study visit (approximately 3 hours)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月1日

一次修了 (推定)

2027年11月1日

研究の完了 (推定)

2028年11月1日

試験登録日

最初に提出

2026年8月10日

QC基準を満たした最初の提出物

2026年8月25日

最初の投稿 (実際)

2026年8月28日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月28日

QC基準を満たした最後の更新が送信されました

2026年8月25日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 1817327-27
  • 1R01HD111514-01A1 (米国 NIH グラント/契約)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

De-identified data sets of all individual participant data collected throughout the trial will be made available, in machine-readable format, on the Eunice Kennedy Shriver National Institute of Child Health and Human Development Data and Specimen Hub. The de-identification procedures will follow 164.514(a) of the Health Insurance Portability and Accountability Act Privacy Rule.

IPD 共有時間枠

Publication-associated datasets will be submitted to Data and Specimen Hub at least 4 months prior to publication so that data can be shared on or before the initial publication date. The full study dataset will be submitted to Data and Specimen Hub at least 6 months prior to the end of the award period. The Data and Specimen Hub do not currently have any data deprecation or sunsetting protocols, allowing shared data to be preserved for the foreseeable future.

IPD 共有アクセス基準

The Data and Specimen Hub are a National Institutes of Health controlled-access data repository. The Eunice Kennedy Shriver National Institute of Child Health and Human Development Data and Specimen Hub Data Access Committee reviews all requests to access Data and Specimen Hub data from identity-verified requesters to determine whether the proposed use is scientifically and ethically appropriate and does not conflict with constraints or research data use limitations identified by the institutions that submitted the research data. The Recipient's institution and the Recipient must sign and agree to the terms and conditions in the N Eunice Kennedy Shriver National Institute of Child Health and Human Development Data and Specimen Hub Data Use Agreement for accessing research data.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • ICF

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

はい

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する